“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
Loan Practices of China’s Biggest Banks Raising Concern
Cypriot finance minister says "no truth" to resignation reports
Jim Bovard: Farmers fight for the right to grow raisins
Mother takes son’s police shooting case to UN Human Rights Committee
Shanghai Futures Exchange To Begin Gold/Silver Night Trading
Eric Holder defends prosecution against Megaupload founder Kim Dotcom
Owner of kite-surfing island for Silicon Valley executives faces $4.6 million fine
What To Expect Next From The American-US Airways Merger
Bakken flaring burns more than $100 million a month
Egypt expels three Al-Jazeera journalists for biased reporting
BIS blames European banks for eternal euro crisis
Nine charged for giving food to homeless in California
High taxes on legal pot in California could mean black market will thrive
Scientists Plan to Block the Sun Using Man-Made Clouds
The Facebook camera that can recognise you every time you walk into a shop